Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9794-9802
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9794
Table 1 Baseline characteristics of patients in the Helicobacter pylori tested group n (%)
H. pyloriH. pyloriH. pyloriP value
negative grouppersistent grouperadicated group
(n = 95)(n = 42)(n = 120)
Sex
Male74 (77.9)29 (69.0)86 (71.7)0.454
Female21 (22.1)13 (31.0)34 (28.3)
Age, mean (SD)68.65 (8.86)67.31 (9.12)64.76 (10.10)0.011
Follow-up period (mo), mean (SD)36.18 (± 26.74)33.29 (± 25.93)32.78 (± 23.72)0.149
Endoscopic mucosal atrophy50 (52.6)8 (19.0)25 (20.8)< 0.001
Intestinal metaplasia63 (66.3)18 (42.9)32 (26.7)< 0.001
Location of primary cancer
Upper10 (10.5)5 (11.9)10 (8.3)0.577
Middle36 (37.9)14 (33.3)35 (29.2)
Lower49 (51.6)23 (54.8)75 (62.5)
Macroscopic type of primary cancer
Elevated40 (42.1)122 (8.6)57 (47.5)0.177
Flat13 (13.7)5 (11.9)9 (7.5)
Depressed42 (37.0)25 (59.5)54 (45.0)
Diameter of primary cancer (cm), mean (SD)14.24 (7.31)13.83 (6.22)13.67 (6.90)0.978
Histology of primary cancer
Differentiated93 (97.9)38 (90.5)118 (98.3)0.032
Undifferentiated2 (2.1)4 (9.5)2 (1.7)
ESD criteria
Absolute73 (76.8)33 (78.6)95 (79.2)0.636
Expended18 (18.9)5 (11.9)19 (15.8)
Beyond expanded4 (4.2)4 (9.5)6 (5.0)
Depth of primary cancer
Mucosa89 (93.7)40 (95.2)111 (92.5)0.819
Submucosa6 (6.3)2 (4.8)9 (7.5)
Metachronous cancer recurrence7 (7.4)1 (2.4)3 (2.5)0.173